Pioneering research and skills
A changing culture
A
n automated system which allows the
culture of a large number of stem cells has
been developed and systems worth £20.1
million sold. This was the result of research
undertaken with Loughborough University where
scientists looked at ways to improve the manual stem cell
culture processes to enable automated therapeutic stem
cell manufacturing which is regulatory compliant and
hence commercially viable stem cell products.
The product was launched by TAP Biosystems and has
a global reach with 40% of the systems sold in Europe
and 60% in the USA. Being able to manufacture stem
cell based products is one of the key critical translational
steps to allow therapies to reach large numbers
of patients and the market for successful business
investment and sector growth.
To download the Growth Stories app
visit www.epsrc.ac.uk/growth